Search

everythinglearnresearchcommunity

for

Search:↓

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

Ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata.

New cancer treatments show promise in reducing tumor growth and improving skin regeneration in mice.

JAK inhibitors effectively regrow hair in alopecia areata but hair loss often returns after stopping treatment.

Targeting amphiregulin may improve treatment for fibrosis and cancer.

Deuruxolitinib significantly helps regrow scalp hair in adults with moderate to severe alopecia areata.

A new protein was made to detect specific skin cell growth receptors and worked in normal skin but not in skin cancer cells.

As skin cells mature, vitamin D receptor levels decrease while retinoid X receptor α levels increase.

Regulatory T cells are essential for normal and improved wound healing in mice.

Using a drug to activate bone marrow stem cells can help the liver regenerate and function better after major surgery in rats.

LRIG1 protein affects hair growth by regulating skin receptors, leading to hair loss when overexpressed.

CD26+ fibroblasts improve skin healing and integration better than CD26− fibroblasts.

Skin tumors with CYLD cutaneous syndrome show more NF-κB activity and less organized collagen.

Lack of KSR1 stops certain skin tumors in mice.

Deuruxolitinib improves hair regrowth in alopecia areata but needs more safety research.

Previous alopecia areata treatments do not affect the long-term effectiveness of ritlecitinib.

The study found that certain mutations in the vitamin D receptor can cause rickets and potentially affect hair growth.

Tofacitinib helped most teenagers in the study regrow hair with mild side effects.

Ritlecitinib helps hair regrowth and reduces emotional and functional burdens in alopecia areata.

JAK inhibitors may help improve symptoms in adults with APECED.

RXR-alpha is strongly expressed in both normal and psoriatic skin and may help in skin cell differentiation and hair growth.

Clinicians should consider individual factors and communicate risks and benefits when prescribing ritlecitinib for adolescent alopecia areata.

A patient's grey hair regained color during treatment with adalimumab.

Redenyl lotion effectively promotes hair growth and improves quality of life for androgenetic alopecia patients.

Ritlecitinib may cause severe musculoskeletal pain in some alopecia universalis patients.

RCS-01 is safe and may help rejuvenate aging skin.

Blocking IL-17 can reduce joint inflammation in Ross River Virus infections.

Tralokinumab successfully treated alopecia areata in a patient with atopic dermatitis.